250mg Geftib Gefitinib Tablets

250mg Geftib Gefitinib Tablets Specification

Life Span
24 months from date of manufacture

Dosage Form
Solid Oral

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 tablets per box

Salt Composition
Gefitinib 250mg

Indication
Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with sensitizing EGFR mutations

Brand Name
Geftib

Packaging Type
Blister pack

Drug Type
Prescription Drug

Ingredients
Gefitinib

Physical Form
Tablets

Function
Antineoplastic (Cancer treatment)

Recommended For
Adults with non-small cell lung cancer (NSCLC)

Dosage
250mg per tablet

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
1 strip of 10 tablets

Storage Instructions
Store in a cool and dry place below 30C, protect from light and moisture

Side Effects
May cause rash, diarrhea, dry skin, nausea, or interstitial lung disease in rare cases

Prescription/Non Prescription
Prescription

Color
White to off-white

Approval
Approved by Indian regulatory authorities

Warning/Precautions
To be used only under medical supervision. Not to be used in pregnancy and lactation unless prescribed.

Marketed By
Cipla Pharmaceuticals

Manufactured By
Cipla Ltd.

Therapeutic Class
Anticancer/Epidermal Growth Factor Receptor (EGFR) inhibitor

Shape
Round

Administration Route
Oral

250mg Geftib Gefitinib Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About 250mg Geftib Gefitinib Tablets

Dose/Strength	250 mg
Form	Tablet
Brand	Geftib
Packaging Size	30 Tablets
Manufacturer	Glenmark Pharmaceuticals Ltd
Pack Type	Bottle
Treatment	Treats Non-Small Cell Lung Cancer

Gefitinib(Iressa) generic Geftib is a chemotherapy agent, prescribed for non-small cell lung cancer. It blocks the action of a certain substance that may be needed for cancer cell multiplication.

Targeted Therapy for NSCLC

Geftib 250mg Gefitinib Tablets specifically target cancer cells in patients with non-small cell lung cancer (NSCLC) that show activating EGFR mutations. This approach helps block the signals that drive cancer cell growth, providing a more focused treatment option compared to standard chemotherapy.

Safe and Supervised Usage

This medication should be used only under strict medical supervision. It is essential to take Geftib exactly as prescribed, and it is not recommended for pregnant or breastfeeding women unless deemed absolutely necessary by your doctor. Regular monitoring and communication with your healthcare provider are crucial during treatment.

Proper Storage and Handling

Geftib tablets must be stored in a cool, dry place below 30C, away from direct light and moisture, to maintain their effectiveness. Each tablet is securely packaged in a blister strip, ensuring stability throughout its 24-month shelf life from the date of manufacture.

FAQ's of 250mg Geftib Gefitinib Tablets:

Q: How should Geftib 250mg Gefitinib Tablets be taken?

A: Geftib should be taken orally once daily or as directed by your physician. It can be taken with or without food, but it is important to follow your doctor's instructions carefully regarding timing and dosage.

Q: What is the main benefit of using Geftib for NSCLC?

A: Geftib is specifically indicated for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that have sensitizing EGFR mutations. It helps slow down or stop the proliferation of cancer cells, potentially leading to better disease control.

Q: When should Geftib not be used?

A: Geftib should not be used during pregnancy or lactation unless your doctor determines it is absolutely necessary. Always inform your healthcare provider of your medical condition and history before starting treatment.

Q: Where should I store Geftib tablets?

A: Store the tablets in a cool and dry place, below 30C, away from direct sunlight and moisture. Keeping the medication within its original blister packaging ensures its stability and effectiveness.

Q: What side effects should I watch out for while taking Geftib?

A: Common side effects may include rash, diarrhea, dry skin, and nausea. In rare cases, patients can develop interstitial lung disease. Contact your doctor immediately if you experience persistent or severe symptoms.

Q: What is the process for obtaining Geftib tablets?

A: Geftib is a prescription-only medication in India, so you will need a valid doctor's prescription. The medicine is supplied in blister packs, with each box containing 30 tablets, and is available through authorized pharmacies.